Bonus Biogroup Stock Technical Analysis
| BBIXF Stock | USD 0.09 0.01 10.00% |
As of the 8th of February, Bonus BioGroup shows the Risk Adjusted Performance of 0.0577, mean deviation of 3.01, and Standard Deviation of 13.28. Bonus BioGroup technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bonus BioGroup variance and skewness to decide if Bonus BioGroup is priced correctly, providing market reflects its regular price of 0.09 per share. As Bonus BioGroup appears to be a penny stock we also recommend to validate its information ratio numbers.
Bonus BioGroup Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bonus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BonusBonus |
Bonus BioGroup 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bonus BioGroup's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bonus BioGroup.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Bonus BioGroup on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Bonus BioGroup or generate 0.0% return on investment in Bonus BioGroup over 90 days. Bonus BioGroup is related to or competes with Starpharma Holdings, Finch Therapeutics, Celyad Oncology, and Cell Source. Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts More
Bonus BioGroup Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bonus BioGroup's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bonus BioGroup upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0531 | |||
| Maximum Drawdown | 110.0 |
Bonus BioGroup Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bonus BioGroup's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bonus BioGroup's standard deviation. In reality, there are many statistical measures that can use Bonus BioGroup historical prices to predict the future Bonus BioGroup's volatility.| Risk Adjusted Performance | 0.0577 | |||
| Jensen Alpha | 0.7242 | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | 1.02 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bonus BioGroup's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bonus BioGroup February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0577 | |||
| Market Risk Adjusted Performance | 1.03 | |||
| Mean Deviation | 3.01 | |||
| Coefficient Of Variation | 1669.57 | |||
| Standard Deviation | 13.28 | |||
| Variance | 176.38 | |||
| Information Ratio | 0.0531 | |||
| Jensen Alpha | 0.7242 | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | 1.02 | |||
| Maximum Drawdown | 110.0 | |||
| Skewness | 6.22 | |||
| Kurtosis | 50.56 |
Bonus BioGroup Backtested Returns
Bonus BioGroup appears to be out of control, given 3 months investment horizon. Bonus BioGroup secures Sharpe Ratio (or Efficiency) of 0.0608, which signifies that the company had a 0.0608 % return per unit of risk over the last 3 months. By analyzing Bonus BioGroup's technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please makes use of Bonus BioGroup's Standard Deviation of 13.28, mean deviation of 3.01, and Risk Adjusted Performance of 0.0577 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bonus BioGroup holds a performance score of 4. The firm shows a Beta (market volatility) of 0.77, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bonus BioGroup's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bonus BioGroup is expected to be smaller as well. Please check Bonus BioGroup's variance, skewness, as well as the relationship between the Skewness and day typical price , to make a quick decision on whether Bonus BioGroup's price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Bonus BioGroup has no correlation between past and present. Overlapping area represents the amount of predictability between Bonus BioGroup time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bonus BioGroup price movement. The serial correlation of 0.0 indicates that just 0.0% of current Bonus BioGroup price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.88 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Bonus BioGroup technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Bonus BioGroup Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Bonus BioGroup volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Bonus BioGroup Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bonus BioGroup on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bonus BioGroup based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bonus BioGroup price pattern first instead of the macroeconomic environment surrounding Bonus BioGroup. By analyzing Bonus BioGroup's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bonus BioGroup's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bonus BioGroup specific price patterns or momentum indicators. Please read more on our technical analysis page.
Bonus BioGroup February 8, 2026 Technical Indicators
Most technical analysis of Bonus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bonus from various momentum indicators to cycle indicators. When you analyze Bonus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0577 | |||
| Market Risk Adjusted Performance | 1.03 | |||
| Mean Deviation | 3.01 | |||
| Coefficient Of Variation | 1669.57 | |||
| Standard Deviation | 13.28 | |||
| Variance | 176.38 | |||
| Information Ratio | 0.0531 | |||
| Jensen Alpha | 0.7242 | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | 1.02 | |||
| Maximum Drawdown | 110.0 | |||
| Skewness | 6.22 | |||
| Kurtosis | 50.56 |
Bonus BioGroup February 8, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Bonus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.90 | ||
| Day Median Price | 0.09 | ||
| Day Typical Price | 0.09 | ||
| Price Action Indicator | (0.01) |
Complementary Tools for Bonus Pink Sheet analysis
When running Bonus BioGroup's price analysis, check to measure Bonus BioGroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus BioGroup is operating at the current time. Most of Bonus BioGroup's value examination focuses on studying past and present price action to predict the probability of Bonus BioGroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus BioGroup's price. Additionally, you may evaluate how the addition of Bonus BioGroup to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |